Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery

• Published in: JAAD international Vol. 14; pp. 39 - 47
• Main Authors: Tan, Eugene, Lim, Sophie, Lamont, Duncan, Epstein, Richard, Lim, David, Lin, Frank P.Y.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.2024; Elsevier
• Subjects: artificial intelligence; basal cell carcinoma; deep learning; digital pathology; Mohs micrographic surgery; Original; squamous cell carcinoma; BCC; AI; AUROC; LOOCV; NMSC; artificial intelligence; FMV; deep learning; Mohs micrographic surgery; WSL; MMS; SCC; digital pathology; AUPRC; basal cell carcinoma; squamous cell carcinoma
• ISSN: 2666-3287; 2666-3287
• DOI: 10.1016/j.jdin.2023.10.007

Real-time review of frozen sections underpins the quality of Mohs surgery. There is an unmet need for low-cost techniques that can improve Mohs surgery by reliably corroborating cancerous regions of interest and surgical margin proximity. To test that deep learning models can identify nonmelanoma skin cancer regions in Mohs frozen section specimens. Deep learning models were developed on archival images of focused microscopic views (FMVs) containing regions of annotated, invasive nonmelanoma skin cancer between 2015 and 2018, then validated on prospectively collected images in a temporal cohort (2019-2021). The tile-based classification models were derived using 1423 focused microscopic view images from 154 patients and tested on 374 images from 66 patients. The best models detected basal cell carcinomas with a median average precision of 0.966 and median area under the receiver operating curve of 0.889 at 100x magnification (0.943 and 0.922 at 40x magnification). For invasive squamous cell carcinomas, high median average precision of 0.904 was achieved at 100x magnification. Single institution study with limited cases of squamous cell carcinoma and rare nonmelanoma skin cancer. Deep learning appears highly accurate for detecting skin cancers in Mohs frozen sections, supporting its potential for enhancing surgical margin control and increasing operational efficiency. [Display omitted]